This site is intended for health professionals only

Home
>
Editor’s pick

Editor’s pick

NICE approves cancer-drug Revlimid

NICE approves cancer-drug Revlimid

Novartis announce collaboration

Novartis announce collaboration

Strong financial results for Novartis

Strong financial results for Novartis

Novartis and Medicines for Malaria Venture announce launch of Coartem Dispersible

Novartis and Medicines for Malaria Venture announce launch of Coartem Dispersible

Lundbeck to sell shares

Lundbeck to sell shares

Huntington’s research stepped up

Huntington’s research stepped up

Pfizer to acquire Wyeth

Pfizer to acquire Wyeth

Dermatitis ointment cleared by EMEA

Dermatitis ointment cleared by EMEA

Drug hope for psoriasis sufferers

Drug hope for psoriasis sufferers

Ustekinumab approved for use by the European Commission

Ustekinumab approved for use by the European Commission

UCB receives €515 million from GSK

UCB receives €515 million from GSK

Thalidomide used to fight cancer

Thalidomide used to fight cancer

« Previous 1 … 154 155 156 157 158 … 302 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x